Semiconductor manufacturing equipment supplier Lam Research (NASDAQ: LRCX) has been in fine form on the stock market in 2025, ...

CEO Taj Singh comments: "2024 was a defining year for First Nordic as we laid the groundwork to become a leading gold explorer and developer. Receiving the TSX Venture 50 award is a testament to our ...

This is Michael Sieffert, Chief Financial Officer of GreenPower Motor Company. I’d like to welcome everyone to our call to ...

Developed in collaboration with Norway's major anti-aging research institute NO-Age, the Ageless Beauty Nourishing Krill Oil ...

Biotage AB posted the largest decline among large stocks during the session, plummeting 21.7%, followed by AF Gruppen ASA shares, which declined 7.8%. Shares of Lindab International AB dropped 5.4%.

Nordic stocks rose Tuesday, with the OMX Nordic 40 Index rising 1.4%. Truecaller AB Series B was the biggest leader among large stocks during the session, surging 18.5%, and BW LPG Ltd. gained 4.4%.

Nordic stocks gained Monday, with the OMX Nordic 40 Index rising 1.1%. Saab AB Series B was the biggest leader among large stocks during the session, surging 16.2%, and BioArctic AB Series B rose 9.1% ...

Sweden-listed Hoegh Autoliners ASA posted the largest decline among large stocks during the session, declining 9.7%, followed by Norway-listed Hoegh Autoliners ASA shares, which fell 9.4%. Shares of ...

Euronext N.V. reports strong Q4 2024 earnings with double-digit growth, strategic acquisitions, and innovation.

International SA reported strong earnings for the fourth quarter of 2024, with an earnings per share (EPS) of $1.59, surpassing the forecast of $1.37. Revenue reached $1.34 billion, exceeding ...

HELSINKI - Sampo plc, a leading Nordic insurance group, announced today that Morten Thorsrud, classified as a senior manager within the company, has acquired a total of 7,500 shares in two separate ...

In early trading on Thursday, shares of AstraZeneca topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.4%. Year to date, AstraZeneca registers a 13.0% gain.